Delivery Order SPE2DP21D0006-SPE2DP21F2379
Award Date 2/26/21
Potential Completion Date 8/20/21
Potential Value $9.8M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical awarded an $18.8 million firm fixed price delivery order contract to Glaxosmithkline, LLC for Influenza Virus Vaccines. The prime contractor Glaxosmithkline, LLC will perform the work at their facility located in Research Triangle Park, North Carolina. The period of performance is from August 31, 2022 through August 31, 2022. No applicable subcontractors were identified.</p>
- The Defense Logistics Agency Troop Support Medical awarded Glaxosmithkline, LLC a $463,000 firm fixed price delivery order contract to supply influenza virus vaccines. As the prime contractor, Glaxosmithkline will deliver the vaccines from its Research Triangle Park, North Carolina facility to support DLA Troop Support Medical's influenza virus vaccination program. The contract runs from March 22, 2021 through November 12, 2021. No set aside designation or subcontractors were indicated. DLA...
- The Defense Logistics Agency Troop Support Medical awarded a $217,170 delivery order to Glaxosmithkline, LLC for influenza virus vaccinations. Glaxosmithkline will deliver the requested vaccinations as the prime contractor, performing the work out of its Research Triangle Park, North Carolina facility. The firm fixed price contract runs from March 22, 2021 through November 12, 2021 to support the Defense Logistics Agency's medical programs. No set aside designation or subcontractors were...
- This is a federal contract award to Glaxosmithkline, LLC, a pharmaceutical company, from the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $3,820.80 and is a firm fixed price delivery order with a completion date of November 12, 2018. The contract does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to various U.S. government agencies through federal contracts and...
- This federal contract award was issued by the Medical Supply Chain division of the U.S. Department of Defense to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The firm fixed price delivery order, valued at $29,850, has an ultimate completion date of October 19, 2018. The contract was not set aside for any socioeconomic category. Glaxosmithkline, LLC has also received multiple award indefinite delivery vehicles from the Centers for Disease...
- This federal contract award, with ID SPE2DP18D0006|SPE2DP19F0456, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The contract is a firm fixed-price Delivery Order with a ceiling value of $173,368.80 and a period of performance ending on November 8, 2018. The contract was not set aside for any specific business designation. Glaxosmithkline, LLC has provided a range of pharmaceutical goods and...
- This federal contract award, SPE2DP18D0006|SPE2DP19F0375, was issued by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The $53,730.00 firm fixed price delivery order has a period of performance ending on November 7, 2018 and was placed under a larger DLA pharmaceutical supply contract vehicle. The contract does not have a set-aside designation. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, has also received other...
- This federal contract award for $2,408,448.00 was issued by the Medical Supply Chain division of the U.S. Department of Defense to the pharmaceutical company Glaxosmithkline, LLC for the delivery of influenza virus vaccines. The contract is a firm fixed price delivery order with no set-aside designation, and performance will occur at Glaxosmithkline's facilities in North Carolina. This award is part of a larger indefinite delivery vehicle (IDV) contract held by Glaxosmithkline to provide a range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of 8502637428 influenza virus vaccine. The $100,660.00 contract has a performance period ending on November 30, 2015 and was not set aside for any socioeconomic category. Glaxosmithkline holds multiple federal contract vehicles with agencies like the Department of Veterans Affairs, Centers for Disease Control and Prevention, and DLA to...
- This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Glaxosmithkline, LLC, a pharmaceutical company, to provide flu vaccine for Fiscal Year 2019. The contract has a total potential value of $130,416.00 and is a firm fixed price agreement with no set-aside designation. The place of performance is Research Triangle Park, North Carolina. Glaxosmithkline has multiple federal contracts and indefinite delivery vehicles to supply vaccines and...